Human papillomavirus (HPV) vaccine initiation and HPV and vaccine awareness among men 18–26 years in the United States, 2010

Details

• Alternative Title:
  Am J Prev Med
• Personal Author:
  Lu, Peng-jun ; Williams, Walter W. ; Li, Jun ; Dorell, Christina ; Yankey, David ; Kepka, Deanna ; Dunne, Eileen F.
• Description:
  Background ; In 2009, the quadrivalent Human Papillomavirus (HPV) vaccine was licensed by the Food and Drug Administration (FDA) for use in males 9 through 26 years. In 2009, the Advisory Committee on Immunization Practices (ACIP) provided a permissive recommendation allowing the administration of HPV vaccine to males 9 through 26 years. ; Purpose ; To assess HPV vaccination coverage, evaluate awareness of HPV and HPV vaccine, and identify factors independently associated with awareness of HPV and HPV vaccine among men 18-26 years. ; Methods ; We analyzed data from the 2010 National Health Interview Survey (NHIS), to evaluate initiation of HPV vaccination, assess awareness of HPV and the HPV vaccine, and identify factors associated with awareness of HPV and the HPV vaccine among men 18–26 years. ; Results ; In 2010, HPV vaccination initiation among men 18-26 years was 1.1%. Among the 1,741 men 18-26 years interviewed, nearly half had heard of HPV (51.8%). Overall, about one third of men 18-26 years had heard of the HPV vaccine (34.8%). Factors independently associated with a higher likelihood of awareness of both HPV and HPV vaccine among men 18-26 years included non-Hispanic white race/ethnicity, higher education, birth in the United States, a greater number of physician contacts, private health insurance, receipt of other vaccines, and reporting risk behaviors related to sexually transmitted diseases, including HIV. ; Conclusions ; HPV vaccination initiation among men 18-26 years in 2010 was low. HPV and HPV vaccine awareness were also low and communication messages directed to men are needed. Since ACIP published a recommendation for routine use of HPV4 among males in December 2011, continued monitoring of HPV vaccination uptake among men 18-26 years is useful for evaluating the vaccination campaigns and for planning and implementing strategies for increasing vaccination coverage.
• Keywords:
  • human papillomavirus
  • human papillomavirus vaccine
  • adult vaccination
  • vaccination coverage
  • Adolescent
  • Adult
  • Drug Approval
  • Health Knowledge, Attitudes, Practice
  • Health Surveys
  • Humans
  More +
• Source:
  Am J Prev Med. 44(4):330-338
• Pubmed ID:
  23498097
• Pubmed Central ID:
  PMC5822442
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  44
• Issue:
  4
• Download URL:
  https://stacks.cdc.gov/view/cdc/52059/cdc_52059_DS1.pdf
• File Type:
  [PDF - 360.55 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:b4c6b7d7edcd91364a27a235189ed98d7413f4105a002bb061c81f1f866af48b